<DOC>
	<DOC>NCT00610545</DOC>
	<brief_summary>This study is designed to determine if the use of atorvastatin (Lipitor), a member of the HMG coA reductase inhibitor class of drugs referred to as statins, will reduce cardiovascular outcomes ( mortality - myocardial infarction - stroke ) when given in high doses in comparative standard doses in the perioperative period of major vascular surgery. Abdominal aortic aneurysm , Carotid endarterectomy , Revascularization of lower limbs</brief_summary>
	<brief_title>Atorvastatin in Perioperative Vascular Surgery - Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Vascular surgery (abdominal aortic aneurysm , carotid endarterectomy , limbs revascularization) Pregnant or lactating women Patient with sensitivity to atorvastatin Patient has elevations in certain laboratory values (CK, AST, ALT) Known history of active hepatic disease or known hepatic insufficiency Patients participating in another clinical trial Prior statin therapy to include: &gt;10 mg of atorvastatin (Lipitor) or &gt;20 mg of other HMGCoA Reductase Inhibitors (statins) or use rosuvastatin Serious infectious disease after surgery Known history of cancer</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>ATORVASTATIN</keyword>
	<keyword>VASCULAR SURGERY</keyword>
	<keyword>CARDIOVASCULAR OUTCOMES</keyword>
</DOC>